Gülben Kaptan, Berberoğlu Uğur, Boyabatli Mustafa
Department of Surgery, Ankara Oncology Education and Research Hospital, Demetevler, Ankara, TR-06200, Turkey.
World J Surg. 2006 Jan;30(1):84-90. doi: 10.1007/s00268-005-7949-z.
Medullary thyroid carcinoma (MTC) originates from the thyroid parafollicular cells and accounts for 3% to 10% of all thyroid malignancies. Approximately 84% of cases are sporadic. The aim of this study was to evaluate the outcomes of treatment for sporadic medullary thyroid carcinoma (SMTC) and define the prognostic factors for overall survival.
The records of 32 SMTC patients treated at Ankara Oncology Education and Research Hospital between September 1993 and April 2003 were retrospectively evaluated. The effects of age, gender, tumor localization, extent of the primary surgical resection, tumor size, capsule invasion, lymph node metastasis, extranodal extension, tumor stage, local recurrence, and distant metastasis on the overall survival rate were evaluated by univariate and multivariate analyses.
There were 32 patients (19 females, 13 males) with a median age of 45 years (21-76 years). Altogether, 22 patients had undergone complete resection and 10 patients incomplete resection. The median follow-up was 48 months (9-111 months), and the overall 5-year survival rate was 51%. Based on the univariate analysis, the extent of primary surgical resection, pathologic tumor size, capsule invasion, lymph node invasion, extranodal extension, tumor stage, local recurrence, and distant metastasis were factors that significantly affected survival. In the multivariate analysis, however, only the extent of the primary surgical resection, capsule invasion, and distant metastasis were found to be statistically significant factors.
The extent of the primary surgical resection significantly influences the survival of patients with SMTC. Capsule invasion and distant metastasis were additional factors affecting the prognosis.
甲状腺髓样癌(MTC)起源于甲状腺滤泡旁细胞,占所有甲状腺恶性肿瘤的3%至10%。约84%的病例为散发性。本研究的目的是评估散发性甲状腺髓样癌(SMTC)的治疗效果,并确定总体生存的预后因素。
回顾性评估了1993年9月至2003年4月在安卡拉肿瘤学教育与研究医院接受治疗的32例SMTC患者的记录。通过单因素和多因素分析评估年龄、性别、肿瘤定位、初次手术切除范围、肿瘤大小、包膜侵犯、淋巴结转移、结外扩展、肿瘤分期、局部复发和远处转移对总体生存率的影响。
共有32例患者(19例女性,13例男性),中位年龄45岁(21 - 76岁)。总共22例患者接受了根治性切除,10例患者接受了非根治性切除。中位随访时间为48个月(9 - 111个月),总体5年生存率为51%。基于单因素分析,初次手术切除范围、病理肿瘤大小、包膜侵犯、淋巴结侵犯、结外扩展、肿瘤分期、局部复发和远处转移是显著影响生存的因素。然而,在多因素分析中,仅发现初次手术切除范围、包膜侵犯和远处转移是具有统计学意义的因素。
初次手术切除范围显著影响SMTC患者的生存。包膜侵犯和远处转移是影响预后的其他因素。